QUERETARO, Mexico, July 30, 2013 /PRNewswire/ -- The company CELLMAK is dedicated to biomedical research in regenerative cellular medicine and tissue engineering with a group of scientists led by Biomedical Researcher Mario Camacho.
Five years ago we began our work on clinical research protocols for the functional Regeneration of the Retina, working with cases of Age-related Macular, Glaucoma and Optic Nerve Atrophy, using autologous stem cells from bone marrow with excellent results. In other countries, at present they are only in the initial clinical research protocols for these ailments.
We do not commercialize treatments, but since we do not have support from the government or large companies, patients, who are evaluated by the ophthalmologists we work with as viable candidates for our protocols, pay out of their own pockets for the inputs and medical fees involved.
We Mexicans are proud to be competing with research groups from all over the world, many of them endowed with multi-million dollar support from their governments or major corporations.
CELLMAK has distinguished itself as the first company in Latin America successfully to introduce Cellular Facial Rejuvenation to the market, using the patient's own fatty tissue cells, and without surgery!
We are located in the city of Queretaro, one of the safest and most beautiful cities in Mexico, where people come to see us from all over the world.
Our protocols depend on COFEPRIS, Mexico's regulatory agency for health matters. At present the FDA has no role whatsoever in regulating us.
CELLMAK is a company founded by Biomedical Researcher Mario Camacho and his wife, Karyna Camacho, who have worked indefatigably to create the technology and appropriate standards for the application of autologous stem cells (that is, using the patient's own stem cells) for Mexico and the world.
At CELLMAK we work to improve the quality of people's lives, and are putting Mexico in first place, competing at the global level in the generation of new technology.
Make an appointment now and find out how you can participate in our clinical research protocols.
Mario Camacho is a Biomedical Researcher engaged in comprehensive handling of autologous stem cells, and he works with medical specialists who clinically evaluate viable candidates and deal directly with the patients.
Copyright©2012 PR Newswire.
All rights reserved